21 completed, 2 recruiting, 1 active not recruiting. 11 Phase 4, 4 Phase 2, 4 Phase 3, 2 Not applicable, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 10, Active not recruiting 1 |
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 3 | 4 | Completed 4 |
| Not applicable | 2 | Completed 2 |
| Phase 1 | 2 | Completed 2 |
Follow fluad vaccine: new trials by email Literature Review of fluad vaccine trials Research Report on fluad vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Systems Investigation of Vaccine Responses in Aging and Frailty Fluzone, Fluad - Influenza | Phase 2 | Recruiting | Yale University | 96 | 2023-11-06 | 2025-06-12 |
| Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4), High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4) - Influenza, Community-acquired Pneumonia | Recruiting | Kaiser Permanente | 1500000 | 2023-08-17 | 2026-08-05 | |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults mRNA-1010, Egg-based Quadrivalent Influenza Vaccine, Adjuvanted Quadrivalent Influenza Vaccine - Influenza | Phase 2 | Completed | ModernaTX, Inc. | 172 | 2022-11-02 | 2025-11-24 |
| A Study of Modified mRNA Vaccines in Healthy Adults mRNA-1273, mRNA-1010, mRNA-1345 - SARS-CoV-2, Seasonal Influenza | Phase 1 | Completed | ModernaTX, Inc. | 308 | 2022-05-24 | 2026-03-12 |
| B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults Fluzone, Flucelvax, Fluzone High-Dose - Influenza | Phase 4 | Active not recruiting | University of Alabama at Birmingham | 50 | 2021-04-01 | 2026-05-14 |
| Senescent Immunity in Elders and Vaccine Responses (SILVER) Fluzone-High Dose Quadrivalent, Fluad, Flublock - Flu Vaccine | Phase 4 | Completed | Vanderbilt University Medical Center | 10 | 2019-10-21 | 2022-07-12 |
| FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care Fluad Vaccine, Fluzone HD Vaccine - Flu | Phase 4 | Completed | David H. Canaday | 478 | 2018-09-23 | 2024-04-30 |
| Gene Signatures of Influenza Vaccine Responses in Older Adults Fluad Vaccine, Fluzone High-Dose - Influenza | Phase 4 | Completed | Mayo Clinic | 241 | 2018-08-27 | 2023-05-16 |
| Effects of Aging on Primary and Secondary Vaccine Responses Fluzone® quadrivalent, Fluzone High Dose, Fluad - Influenza, Hepatitis A | Phase 1 | Completed | Stanford University | 54 | 2017-09-19 | 2024-12-16 |
| FLUAD® vs. Fluzone® High-Dose Study FLUAD®, Fluzone® High-Dose - Pain, Quality of Life | Phase 4 | Completed | Duke University | 757 | 2017-08-28 | 2021-03-30 |
| Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children Fluad, Fluzone - Influenza | Phase 4 | Completed | McMaster University | 3425 | 2016-11-01 | 2024-11-21 |
| Adjuvanted Influenza Vaccination in U.S. Nursing Homes adjuvanted trivalent influenza vaccine, trivalent influenza vaccine - Influenza, Influenza-like Illness | Phase 4 | Completed | Insight Therapeutics, LLC | 823 | 2016-04-01 | 2023-03-15 |
| ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults MF59 - ATIV - Influenza | Phase 2 | Completed | University of Oxford | 120 | 2015-08-01 | 2023-12-07 |
| Gene Expression Profiles in Muscle After Immunisation Fluad, Fendrix, Placebo - Healthy | Not applicable | Completed | University of Surrey | 45 | 2015-02-01 | 2015-08-10 |
| Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses Fluad, Saline - Safety Markers of Adjuvanted Influenza Vaccine | Phase 4 | Completed | University Hospital, Ghent | 240 | 2014-10-02 | 2022-12-20 |
| Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Fluad and Prevenar13, Fluad, Prevenar13 - Influenza, Streptococcus Pneumoniae | Phase 4 | Completed | Korea University Guro Hospital | 1195 | 2014-09-01 | 2015-04-01 |
| Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Fluad, Agrippal - Influenza, End Stage Renal Failure | Phase 4 | Completed | Korea University Guro Hospital | 174 | 2013-10-01 | 2016-02-19 |
| Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa Adjuvanted seasonal trivalent inactivated influenza vaccine, Seasonal trivalent inactivated influenza vaccine, Saline (bacteriostatic 0.9% sodium chloride for injection) - Influenza | Phase 2 | Completed | PATH | 296 | 2013-04-01 | 2013-10-22 |
| Training Study to Characterize Biomarkers to Flu Vaccines Fluad, Agrippal, Placebo - Healthy | Not applicable | Completed | University of Surrey | 49 | 2013-01-01 | 2015-02-16 |
| Comparison of 4 Influenza Vaccines in Seniors Agriflu, Fluad, Intanza - Influenza Vaccine | Phase 4 | Completed | University of British Columbia | 953 | 2011-07-01 | 2015-04-15 |
Showing 20 of 24. Sign in to see all of them.
Influenza, Human (21) · COVID-19 (1) · Community-Acquired Pneumonia (1) · Coronavirus Infections (1) · Cytomegalovirus Infections (1) · Diabetes Mellitus (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1) · Hepatitis A (1) · Injection Site Reaction (1) · Lung Diseases (1) · Pain (1) · Renal Insufficiency, Chronic (1) · Typhoid Fever (1) · Virus Diseases (1)
Korea University Guro Hospital (2) · ModernaTX, Inc. (2) · Novartis Vaccines (2) · University of Surrey (2) · Chiltern Pesquisa Clinica Ltda (1) · David H. Canaday (1) · Duke University (1) · Insight Therapeutics, LLC (1) · Kaiser Permanente (1) · Mayo Clinic (1) · McMaster University (1) · Novartis (1) · PATH (1) · Stanford University (1) · University Hospital, Ghent (1)
United States (12) · United Kingdom (3) · Canada (2) · Philippines (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Chile (1) · Colombia (1) · Finland (1) · Germany (1) · Italy (1) · Panama (1) · Senegal (1)
Hee Jin Cheong, MD, PhD (2) · Albert Shaw, MD, PhD (1) · Aldiouma Diallo, MD (1) · Aldona Greenwood (1) · Andrew J Pollard, PhD (1) · Cornelia Dekker, MD (1) · David Canaday, MD (1) · David Lewis (1) · David W Scheifele, MD (1) · Elizabeth Barnett, MD (1) · Geert Leroux-Roels, Prof,MD (1) · H. Edward Davidson, PharmD, MPH (1) · James J Kobie, PhD (1) · John C Victor, PhD, MPH (1)
PMID 27490698, PMID 21995388, PMID 22872731, PMID 25045825, PMID 25223266, PMID 27336786, PMID 27919632, PMID 30224199, PMID 31889148, PMID 32882710, PMID 33400778, PMID 33443580, PMID 36951196, PMID 37393237, PMID 38077624, PMID 40276503, PMID 40373825, PMID 41398408, PMID 41535296, PMID 42081247
R01AI129709 (1), R01AI130398 (1), R01AI132348 (1), U19AI089992 (1)